Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)
David R. Spigel(Sarah Cannon), Michael McCleod(Sarah Cannon), Robert M. Jotte(Texas Oncology), Lawrence H. Einhorn(Indiana University – Purdue University Indianapolis), Leora Horn(Vanderbilt University Medical Center), David Waterhouse(Oncology Hematology Care), Ben Creelan(Moffitt Cancer Center), Sunil Babu(Fort Wayne Medical Institute), Natasha B. Leighl(University Health Network), Jason C. Chandler(West Cancer Center), Félix Couture(Centre intégré de santé et de services sociaux de Chaudière-Appalaches), George P. Keogh(Charleston Hematology Oncology Associates), Glenwood Goss(University of Ottawa), Davey B. Daniel(Tennessee Oncology), Edward B. Garon, Lee S. Schwartzberg(West Cancer Center), Rohini Sen(Adelphi Laboratory Center), Beata Korytowsky(Bristol-Myers Squibb (United States)), Ang Li(Bristol-Myers Squibb (United States)), Nivedita Aanur(Bristol-Myers Squibb (United States)), Maen Hussein(Sarah Cannon)
Cited by 187
Abstract
Related Papers
No related papers found
Powered by citation graph analysis